AAAAAA

   
Results: 1-15 |
Results: 15

Authors: JOHNSON DM DOERN GV HAUGEN TA HINDLER J WASHINGTON JA JONES RN
Citation: Dm. Johnson et al., COMPARATIVE ACTIVITY OF 12 BETA-LACTAM DRUGS TESTED AGAINST PENICILLIN-RESISTANT STREPTOCOCCUS-PNEUMONIAE FROM 5 MEDICAL-CENTERS - EFFECTS OF SERUM-PROTEIN AND CAPSULAR MATERIAL ON POTENCY AND SPECTRUM AS MEASURED BY REFERENCE TESTS, Diagnostic microbiology and infectious disease, 25(3), 1996, pp. 137-141

Authors: FUCHS PC BARRY AL BROWN SD ALLEN S DOERN G FERRARO MJ HARDY D HINDLER J JENKENS S MCLAUGHLIN J MURRAY P SEWELL D
Citation: Pc. Fuchs et al., SURVEY OF ANTIMICROBIAL ACTIVITY OF 4 COMMONLY USED 3RD-GENERATION CEPHALOSPORINS TESTED AGAINST RECENT BACTERIAL ISOLATES FROM 10 AMERICANMEDICAL-CENTERS, AND ASSESSMENT OF DISK DIFFUSION TEST-PERFORMANCE, Diagnostic microbiology and infectious disease, 24(4), 1996, pp. 213-219

Authors: WORTH S ERWIN ME JONES RN WANGER A WASHINGTON JA DOERN GV HINDLER J HAUGEN TH APPELBAUM PC JACOBS MR MURRAY P SEWELL D
Citation: S. Worth et al., QUALITY-CONTROL GUIDELINES FOR AMOXICILLIN, AMOXICILLIN-CLAVULANATE, AZITHROMYCIN, PIPERACILLIN-TAZOBACTAM, ROXITHROMYCIN, TICARCILLIN, TICARCILLIN-CLAVULANATE, TROVAFLOXACIN (CP-99,219), U-100592, AND U-100766 FOR VARIOUS TIONAL-COMMITTEE-FOR-CLINICAL-LABORATORY-STANDARDS SUSCEPTIBILITY TESTING METHODS - RESULTS FROM MULTICENTER TRIALS, Diagnostic microbiology and infectious disease, 24(2), 1996, pp. 87-91

Authors: FUCHS PC BARRY AL BROWN SD ALLEN S BAUMAN M BRUCKNER D HINDLER J DOERN G FERRARO MJ HARDY D JENKINS S MCLAUGHLIN J MURRAY P SEWELL D
Citation: Pc. Fuchs et al., PREVALENCE OF RESISTANCE TO 3 FLUOROQUINOLONES - ASSESSMENT OF LEVOFLOXACIN DISK TEST ERROR RATES AND SURROGATE PREDICTORS OF LEVOFLOXACIN SUSCEPTIBILITY, Antimicrobial agents and chemotherapy, 40(7), 1996, pp. 1633-1639

Authors: REID R BRADLEY JS HINDLER J
Citation: R. Reid et al., PNEUMOCOCCAL MENINGITIS DURING THERAPY OF OTITIS-MEDIA WITH CLARITHROMYCIN, The Pediatric infectious disease journal, 14(12), 1995, pp. 1104-1105

Authors: SWENSON JM FERRARO MJ SAHM DF CLARK NC CULVER DH TENOVER FC CHARACHE P HOPKINS J HARRELL LJ RELLER LB HARDY D MOELLERING RC WILSON W HINDLER J
Citation: Jm. Swenson et al., MULTILABORATORY EVALUATION OF SCREENING METHODS FOR DETECTION OF HIGH-LEVEL AMINOGLYCOSIDE RESISTANCE IN ENTEROCOCCI, Journal of clinical microbiology, 33(11), 1995, pp. 3008-3018

Authors: SWENSON JM CLARK NC SAHM DF FERRARO ML DOERN G HINDLER J JORGENSEN JH PFALLER MA RELLER LB WEINSTEIN MP ZABRANSKY RJ TENOVER FC
Citation: Jm. Swenson et al., MOLECULAR CHARACTERIZATION AND MULTILABORATORY EVALUATION OF ENTEROCOCCUS-FAECALIS ATCC-51299 FOR QUALITY-CONTROL OF SCREENING-TESTS FOR VANCOMYCIN AND HIGH-LEVEL AMINOGLYCOSIDE RESISTANCE IN ENTEROCOCCI, Journal of clinical microbiology, 33(11), 1995, pp. 3019-3021

Authors: DOERN GV JONES RN GERLACH EH HINDLER J STAMAND R
Citation: Gv. Doern et al., REVISED DISK DIFFUSION INTERPRETIVE CRITERIA FOR CEFACLOR, LORACARBEF, CEFPROZIL AND CEFIXIME WHEN TESTING HAEMOPHILUS-INFLUENZAE ON HAEMOPHILUS TEST MEDIUM, European journal of clinical microbiology & infectious diseases, 13(6), 1994, pp. 481-489

Authors: JONES RN SADER HS ERWIN ME ALDRIDGE K DOERN GV HINDLER J FRITSCHE TR MURRAY PR SEWELL D STEIN G WASHINGTON JA
Citation: Rn. Jones et al., UPDATE OF LOMEFLOXACIN IN-VITRO ACTIVITY AND SPECTRUM - A MULTICENTERTRIAL TESTING CONTEMPORARY PATHOGENS FOLLOWING FOOD-AND-DRUG-ADMINISTRATION VALIDATION GUIDELINES, Diagnostic microbiology and infectious disease, 20(2), 1994, pp. 93-98

Authors: JONES RN KEHRBERG EN ERWIN ME ANDERSON SC BEAVIS K BERMAN M BOURBEAU P SINNOTT J CANAWATI H CAVALIERI S COCKERILL F DELLALATTA P DENYS G DOERN G FORBES B GAMBLE S GOODMAN N HAUGEN T HINDLER J HUMPHRIES J JOSEPHSON S KAUFFMAN C LIBERTINE C MAUNEY C METCHOCK B MICHELSON P MURRAY P NEEDHAM C OELSCHDAEGER R PRICE M SACEANU C SCHWALBE R SEGRETI J SEWELL D SIERRA M SLIFKIN M SNYDMAN D SOUTHERN P SPIEGEL C STEELEMOORE L STEIN G STRATTON C WANGER A WASHINGTON J WASILAUSKAS B WEINSTEIN M
Citation: Rn. Jones et al., PREVALENCE OF IMPORTANT PATHOGENS AND ANTIMICROBIAL ACTIVITY OF PARENTERAL DRUGS AT NUMEROUS MEDICAL-CENTERS IN THE UNITED-STATES .1. STUDYON THE THREAT OF EMERGING RESISTANCES - REAL OR PERCEIVED, Diagnostic microbiology and infectious disease, 19(4), 1994, pp. 203-215

Authors: BALE MJ JONES RN ERWIN ME MURRAY PR WASHINGTON JA GERLACH EH THORNSBERRY C HINDLER J DOERN GV
Citation: Mj. Bale et al., MINIMUM INHIBITORY CONCENTRATION QUALITY-CONTROL GUIDELINES FOR BIAPENEM, DU-6859A, FK-037, LEVOFLOXACIN, GREPAFLOXACIN, AND CEFTIZOXIME WHEN USING VARIOUS NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS SUSCEPTIBILITY TEST METHODS, Diagnostic microbiology and infectious disease, 19(1), 1994, pp. 65-68

Authors: JONES RN DOERN GV GERLACH EH HINDLER J ERWIN ME
Citation: Rn. Jones et al., VALIDATION OF NCCLS MACROLIDE (AZITHROMYCIN, CLARITHROMYCIN, AND ERYTHROMYCIN) INTERPRETIVE CRITERIA FOR HAEMOPHILUS-INFLUENZAE TESTED WITHTHE HAEMOPHILUS TEST MEDIUM, Diagnostic microbiology and infectious disease, 18(4), 1994, pp. 243-249

Authors: BALE MJ JONES RN MURRAY PR WASHINGTON JA GERLACH EH THORNSBERRY C HINDLER J DOERN GV
Citation: Mj. Bale et al., QUALITY-CONTROL GUIDELINES FOR CEFDINIR, CEFEPIME, CEFETAMET, CEFMETAZOLE, CEFPODOXIME, CEFPROZIL, AND CLINAFLOXACIN (CI-960) FOR VARIOUS NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS SUSCEPTIBILITY TESTING METHODS, Journal of clinical microbiology, 31(9), 1993, pp. 2538-2540

Authors: NOVAK SM HINDLER J BRUCKNER DA
Citation: Sm. Novak et al., RELIABILITY OF 2 NOVEL METHODS, ALAMAR AND E-TEST, FOR DETECTION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS, Journal of clinical microbiology, 31(11), 1993, pp. 3056-3057

Authors: TENOVER FC SWENSON J FERRARO MJ HINDLER J JORGENSEN J MURRAY P
Citation: Fc. Tenover et al., CEFUROXIME SCREENING-TEST FOR PNEUMOCOCCI, Journal of clinical microbiology, 31(11), 1993, pp. 3078-3080
Risultati: 1-15 |